{"id":26537,"date":"2021-04-14T12:59:00","date_gmt":"2021-04-14T05:59:00","guid":{"rendered":"https:\/\/www.xinwengao.com\/cn\/pr\/2021041412590026537"},"modified":"2021-04-14T21:41:22","modified_gmt":"2021-04-14T13:41:22","slug":"%e6%b3%9b%e7%94%9f%e5%ad%90%e6%90%ba22%e9%a1%b9%e7%99%8c%e7%97%87%e9%a2%86%e5%9f%9f%e6%96%b0%e7%a0%94%e7%a9%b6%e6%88%90%e6%9e%9c%e4%ba%ae%e7%9b%b82021%e5%b9%b4%e7%be%8e%e5%9b%bd%e7%99%8c%e7%97%87","status":"publish","type":"post","link":"https:\/\/www.xinwengao.com\/cn\/pr\/2021041412590026537","title":{"rendered":"\u6cdb\u751f\u5b50\u643a22\u9879\u764c\u75c7\u9886\u57df\u65b0\u7814\u7a76\u6210\u679c\u4eae\u76f82021\u5e74\u7f8e\u56fd\u764c\u75c7\u7814\u7a76\u534f\u4f1a\u5e74\u4f1a"},"content":{"rendered":"<p><p><span class=\"xn-subheadline\">\u5c01\u9762\u6458\u8981\uff1a\u521b\u65b0\u6280\u672f\u53ca\u4ea7\u54c1\u8d4b\u80fd\u591a\u764c\u79cd\u57fa\u56e0\u7ec4\u5b66\u57fa\u7840\u7814\u7a76\uff0c\u52a9\u529b\u8f6c\u5316\u533b\u5b66\u201c\u826f\u6027\u5faa\u73af\u201d<\/span><\/p>\n<p>\u5317\u4eac2021\u5e744\u670814\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; <b>\u8fd1\u65e5\uff0c\u6cdb\u751f\u5b50\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aGTH\uff09\u57282021\u5e74\u7f8e\u56fd\u764c\u75c7\u7814\u7a76\u534f\u4f1a\u5e74\u4f1a\uff08AACR2021\uff09\u53d1\u5e03\u4e8622\u9879\u5168\u65b0\u7814\u7a76\u6210\u679c\u3002\u4f01\u4e1a\u8fd0\u7528RNA\u878d\u5408\u68c0\u6d4b\u3001\u65b0\u578bMSI\u68c0\u6d4b\u751f\u4fe1\u7b97\u6cd5\u6a21\u578b\u3001\u201c\u4e00\u6b65\u6cd5\u201d\u7b49\u521b\u65b0\u6280\u672f\uff0c\u53caOnco Panscan<sup>TM<\/sup>\u3001\u8089\u7624\u5168\u4f53\u7cfb\u57fa\u56e0\u68c0\u6d4b\u7b49\u6838\u5fc3\u4ea7\u54c1\uff0c\u643a\u624b13\u5bb6\u56fd\u5185\u9876\u7ea7\u533b\u9662\uff0c\u56f4\u7ed5\u4e2d\u56fd\u4eba\u7fa4\u6df1\u5165\u5206\u6790\u80ba\u764c\u3001\u80a0\u764c\u3001\u80f0\u817a\u764c\u3001\u795e\u7ecf\u7cfb\u7edf\u80bf\u7624\u3001\u80f8\u817a\u764c\u7b49\u591a\u764c\u79cd\u9057\u4f20\u3001\u7a81\u53d8\u3001\u878d\u5408\u7279\u5f81\u5206\u5e03\uff0c\u9a8c\u8bc1\u5e76\u6316\u6398\u591a\u764c\u79cd\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269\u6709\u6548\u6027\uff0c\u4ee5\u53ca\u7f55\u89c1\u6848\u4f8b\u548c\u65b0\u578b\u7597\u6cd5\uff0c\u8fdb\u800c\u4e3a\u764c\u75c7\u7cbe\u51c6\u8bca\u7597\u65b9\u5f0f\u3001\u8bca\u7597\u4ea7\u54c1\u8bbe\u8ba1\u7b49\u63d0\u4f9b\u91cd\u8981\u542f\u793a(\u9644\u7814\u7a76\u5217\u8868)\u3002<\/b><\/p>\n<p>\u6cdb\u751f\u5b50\u9996\u5e2d\u533b\u7597\u5b98\u80e1\u4e91\u5bcc\u535a\u58eb\u8868\u793a\uff1a<span id=\"spanHghltb91e\">\u201c<\/span>\u4f5c\u4e3a\u57fa\u7840\u7814\u7a76\u4e0e\u4e34\u5e8a\u5e94\u7528\u7684\u6865\u6881\uff0c\u6cdb\u751f\u5b50\u59cb\u7ec8\u81f4\u529b\u4e8e\u4e3a\u4e8c\u8005\u5efa\u7acb\u826f\u6027\u4e92\u4fc3\u5173\u7cfb\uff0c\u5168\u529b\u63a8\u52a8\u8f6c\u5316\u533b\u5b66\u53d1\u5c55\u3002\u672c\u6b21\u7814\u7a76\u6210\u679c\uff0c\u57fa\u4e8e\u4f01\u4e1a\u521b\u65b0\u6280\u672f\u53ca\u4ea7\u54c1\uff0c\u52a9\u529b\u591a\u764c\u79cd\u57fa\u56e0\u7ec4\u5b66\u7684\u7279\u5f81\u5206\u6790\u53ca\u6280\u672f\u4f18\u5316\u8def\u7ebf\u63a2\u7d22\uff0c\u5e76\u4e3a\u65b0\u4ea7\u54c1\u8bbe\u8ba1\u63d0\u4f9b\u601d\u8def\u3002\u5982\u5728\u8f6f\u7ec4\u7ec7\u8089\u7624\u9886\u57df\uff0c\u901a\u8fc7RNA\u878d\u5408\u68c0\u6d4b\u6280\u672f\uff0c\u5927\u5e45\u63d0\u9ad8\u878d\u5408\u68c0\u51fa\u7387\uff0c\u4e3a\u66f4\u591a\u8089\u7624\u60a3\u8005\u63d0\u4f9b\u83b7\u76ca\u53ef\u80fd\uff1b\u5728\u9057\u4f20\u6027\u80bf\u7624\u9886\u57df\uff0cLi-Fraumeni\u7efc\u5408\u5f81\u7b5b\u67e5\u65b9\u6cd5\u7684\u63d0\u51fa\u4e5f\u5c06\u63d0\u5347\u8be5\u7c7b\u60a3\u8005\u68c0\u51fa\u7387\uff0c\u4e3a\u5176\u63d0\u4f9b\u66f4\u591a\u5e72\u9884\u673a\u4f1a\uff1b\u5728\u7ed3\u76f4\u80a0\u764c\u9886\u57df\uff0cKMT2C\/2D\u5931\u6d3b\u7a81\u53d8\u7684\u5206\u6790\u4e5f\u5c06\u4e3a\u514d\u75ab\u6cbb\u7597\u9002\u7528\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u83b7\u76ca\u53ef\u80fd\u3002\u6b64\u5916\uff0c\u7f55\u89c1\u75c5\u4f8b\u6316\u6398\u53ca\u5176\u65b0\u578b\u7597\u6cd5\u7684\u5c1d\u8bd5\uff0c\u5c06\u63a8\u52a8\u8be5\u7c7b\u578b\u60a3\u8005\u7684\u8bca\u7597\u7814\u7a76\u8fdb\u4e00\u6b65\u53d1\u5c55\u3002<span id=\"spanHghlt75e0\">\u201d<\/span><\/p>\n<p><b>\u63a2\u7d22\u6280\u672f\u4f18\u5316\u8def\u7ebf<\/b><\/p>\n<p>\u4e3a\u6253\u7834DNA-seq\u9488\u5bf9\u68c0\u6d4b\u57fa\u56e0\u878d\u5408\u6240\u5b58\u5728\u7684\u5c40\u9650\u6027\uff0c\u7814\u7a762288\u5bf9\u5e38\u89c4\u6280\u672f\u8fdb\u884c\u4f18\u5316\uff0c\u5728RNA\u5c42\u9762\u5b9e\u73b0\u4e86\u66f4\u7cbe\u51c6\u3001\u9ad8\u6548\u3001\u4f4e\u8017\u7684\u878d\u5408\u57fa\u56e0\u7a81\u53d8\u68c0\u6d4b\uff0c\u5728142\u4eba\u7684\u8f6f\u7ec4\u7ec7\u8089\u7624\u961f\u5217\u4e2d\u8fdb\u884c\u8bc4\u4f30\u53ca\u9a8c\u8bc1\u3002\u7814\u7a76\u663e\u793a\u76f8\u6bd4DNA\u5355\u72ec\u68c0\u6d4b\uff0cDNA+RNA\u7efc\u5408\u68c0\u6d4b\u5bf9\u4e8e\u8f6f\u7ec4\u7ec7\u8089\u7624\u878d\u5408\u7684\u68c0\u51fa\u7387\u63d0\u9ad8\u4e86177%\uff0c\u53ef\u4e3a\u66f4\u591a\u8089\u7624\u60a3\u8005\u63d0\u4f9b\u4e34\u5e8a\u83b7\u76ca\u53ef\u80fd\u3002<\/p>\n<p>\u7814\u7a762080\u5bf9NGS MSI\u751f\u4fe1\u7b97\u6cd5\u8fdb\u884c\u4e86\u591a\u91cd\u4f18\u5316\uff0c\u5e76\u4e0e\u91d1\u6807\u51c6PCR\u5bf9\u6bd4\uff0c\u57282523\u4f8b\u6cdb\u764c\u79cd\u5927\u6837\u672c\u4e2d\u8fdb\u884c\u9a8c\u8bc1\u3002\u7ed3\u679c\u8868\u660e\uff0c\u4f18\u5316\u540e\u7684\u7b97\u6cd5\u4e0e\u91d1\u6807\u51c6PCR\u68c0\u6d4b\u65b9\u6cd5\u4e00\u81f4\u6027\u8fbe99.9%\u3002\u5176\u4e2dMSI-H\u9633\u6027\u9884\u6d4b\u7387PPV\u4e3a98.73%\uff0cMSS\u9634\u6027\u9884\u6d4b\u7387NPV\u4e3a99.92%\u3002<\/p>\n<p><b>\u5173\u6ce8\u9057\u4f20\u6027\u80bf\u7624\u7279\u5f81<\/b><\/p>\n<p>\u4e24\u9879\u7814\u7a76\uff08#1464\u3001#2557\uff09\u901a\u8fc7\u5bf9\u80da\u7cfb\u7a81\u53d8\u7684\u6df1\u5165\u5206\u6790\uff0c\u4e3aLi-Fraumeni\u7efc\u5408\u5f81\u63d0\u4f9b\u4e86\u7b5b\u67e5\u65b9\u6cd5\uff0c\u63a2\u8ba8\u4e86\u4e2d\u56fd\u4eba\u7fa4\u80f0\u817a\u764c\u60a3\u8005\u9057\u4f20\u7279\u5f81\u53ca\u5177\u4f53\u5206\u5e03\uff0c\u4e3a\u9057\u4f20\u6027\u80bf\u7624\u7b5b\u67e5\u53ca\u8bca\u7597\u63d0\u4f9b\u8bc1\u636e\u53ca\u601d\u8def\u3002<\/p>\n<p><b>\u63a2\u7d22\u57fa\u56e0\u7a81\u53d8\u53ca\u878d\u5408\u7279\u5f81<\/b><\/p>\n<p>\u4e5d\u9879\u7814\u7a76\uff08#2217\u3001#2163\u3001#2223\u3001#2216\u3001#2215\u3001#2313\u3001#2252\u3001#2183\u3001#2182\uff09\u5206\u522b\u5bf9\u8f6f\u7ec4\u7ec7\u8089\u7624\u3001\u9ed1\u8272\u7d20\u7624\u3001\u795e\u7ecf\u5185\u5206\u6ccc\u80bf\u7624\u3001\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u3001\u80f8\u817a\u764c\u3001\u5c0f\u80a0\u817a\u764c\u3001\u58f6\u8179\u764c\u7b49\u591a\u4e2a\u764c\u79cd\u8fdb\u884c\u7a81\u53d8\u3001\u878d\u5408\u7279\u5f81\u591a\u7ef4\u5ea6\u63a2\u7d22\uff0c\u5bfb\u627e\u6f5c\u5728\u7cbe\u51c6\u6cbb\u7597\u9776\u70b9\u3001\u8010\u836f\u9776\u70b9\u53ca\u6709\u6548\u5e94\u5bf9\u63aa\u65bd\u3002<\/p>\n<p><b>\u6316\u6398\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269<\/b><\/p>\n<p>\u56db\u9879\u7814\u7a76\uff08#1639\u3001#1640\u3001#1641\u3001#1681\uff09\u5206\u522b\u63a2\u8ba8\u4e86KMT2C\/D\u5931\u6d3b\u7a81\u53d8\u3001DDR\u4fe1\u53f7\u901a\u8def\u76f8\u5173\u57fa\u56e0\u53d8\u5f02\u3001ARID1A\u7a81\u53d8\u4ee5\u53caBRCA1\/2\u7a81\u53d8\u5bf9\u6cdb\u764c\u79cd\u514d\u75ab\u6cbb\u7597\u7597\u6548\u7684\u9884\u6d4b\u4f5c\u7528\uff0c\u4e3a\u514d\u75ab\u6cbb\u7597\u63d0\u4f9b\u542f\u793a\u3002<\/p>\n<p><b>\u5173\u6ce8\u7f55\u89c1\u6848\u4f8b\u53ca\u65b0\u578b\u7597\u6cd5<\/b><\/p>\n<p>\u4e94\u9879\u7814\u7a76\uff08#0803\u3001#0422\u3001#1209\u3001#1199\u3001#0625\uff09\u5206\u522b\u5728\u6797\u5947\u7efc\u5408\u5f81\u76f8\u5173\u80ba\u764c\u3001\u8f6c\u79fb\u6027\u9ed1\u8272\u7d20\u7624\u3001\u95f4\u53d8\u6027\u7532\u72b6\u817a\u764c\u3001\u7532\u72b6\u817a\u4e73\u5934\u72b6\u764c\u4ee5\u53ca\u8102\u80aa\u8089\u7624\u60a3\u8005\u4e2d\u68c0\u6d4b\u51fa\u7279\u6b8a\u7684\u5206\u5b50\u5f02\u5e38\u3002\u7814\u7a76\u901a\u8fc7\u5206\u5b50\u68c0\u6d4b\u8f85\u52a9\u60a3\u8005\u8fdb\u884c\u8bca\u65ad\u5206\u578b\uff0c\u4e3a\u60a3\u8005\u91c7\u7528\u65b0\u578b\u7684\u9776\u5411\u6cbb\u7597\u3001\u514d\u75ab\u6cbb\u7597\u65b9\u6848\uff0c\u6700\u7ec8\u4f7f\u60a3\u8005\u6210\u529f\u83b7\u76ca\u3002<\/p>\n<div>\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tbody>\n<tr>\n<td nowrap class=\"prnsbts prnrbrs prnvab prnsbbs prntac prnpl6 prnsbls prnpr6\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>\u7f16\u53f7<\/b><\/span><\/p>\n<\/td>\n<td nowrap class=\"prnsbts prnrbrs prnvab prnsbbs prntac prnpl6 prnsbl1 prnpr6\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>\u9898\u76ee<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">1464<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Enrichment and screening of LFS patients by analyzing TP53 germline mutations of<br \/>a Chinese cancer cohort<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2252<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Genome profiling of thymic carcinoma identifies putative driver mutations in the NF-<br \/>\u03baB signaling pathway<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2557<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Germline mutation landscape in a large cohort of Chines pancreatic cancer patients<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">0803<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Molecular diagnosis and immunotherapy of a rare lung carcinoma patient associated<br \/>with PMS2 c.1144+1G&gt;A mutation-driven Lynch syndrome<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">0422<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Sequential targeted therapy and immunotherapy of a BRAF positive metastatic<br \/>melanoma patient with BRAF inhibitor vemurafenib, MEK inhibitor cobimetnib and a<br \/>novel PD-1 antibody Sintilimab<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2183<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Genomic profiling of small bowel adenocarcinoma reveals targetable mutations in<br \/>multiple signaling pathways<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2217<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">More somatic mutations can be detected in cerebrospinal fluid ctDNA of NSCLC<br \/>patients with brain metastases<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2182<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Evaluation of somatic and germline mutations in ampullary carcinoma reveals<br \/>actionable targets in multiple signaling pathways<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">1209<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">An effective treatment for recurrent and inoperable anaplastic thyroid carcinoma<br \/>using sintilimab and anlotinib: a case report<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">1681<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Correlation of BRCA1\/2 mutations with response to immune checkpoint inhibitors in <br \/>colorectal cancer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">1641<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">The predictive values of ARID1A mutations for response to immune checkpoint<br \/>inhibitors are varied in different types of solid tumors<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">1639<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Correlation of KMT2C\/D loss-of-function mutations with PD-L1 expression and<br \/>response to immune checkpoint inhibitors in solid tumors<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">1640<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Correlations of DNA damage response gene alterations with response to immune<br \/>checkpoint inhibitors are different in solid tumors<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2288<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Identification of gene fusions in soft tissue sarcoma improved by integrative DNA<br \/>and RNA sequencing<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2163<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Molecular characteristics of CDK4 and\/or MDM2 amplification in Chinese soft tissue<br \/>sarcoma (STS) patients<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">0625<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Co-amplification of CDK4 and MDM2 plus HMGA2 fusion in a patient with myogenic<br \/>differentiation dedifferentiated liposarcoma<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2223<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Distinct genomic features of cutaneous, acral and mucosal melanomas in a Chinese<br \/>retrospective cohort<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2216<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Exploration of the genomic features of pan-neuroendocrine tumors in a Chinese<br \/>retrospective analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2215<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Landscape of RET fusion identified by next\u2013generation sequencing in a Chinese<br \/>multi-cancer retrospective analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">1199<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Mosaic KRAS G12S mutation associates with poor outcome in papillary thyroid<br \/>carcinoma: A case report<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2080<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Tumor microsatellite instability detection method using paired tumor-normal<br \/>sequence data<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td nowrap class=\"prngen4\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">2313<\/span><\/p>\n<\/td>\n<td nowrap class=\"prngen5\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">The characteristics of ERBB2 exon 20 insertion in a large cohort of Chinese NSCLC<br \/>patients<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/div>\n<p>&nbsp;<\/p>\n<p><b>\u5173\u4e8e\u6cdb\u751f\u5b50<\/b><\/p>\n<p>\u6cdb\u751f\u5b50\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aGTH\uff09\u662f\u5168\u7403\u524d\u6cbf\u7684\u764c\u75c7\u7cbe\u51c6\u533b\u7597\u516c\u53f8\uff0c\u4e13\u6ce8\u4e8e\u764c\u75c7\u57fa\u56e0\u7ec4\u5b66\u7814\u7a76\u548c\u5e94\u7528\uff0c\u5e76\u81f4\u529b\u4f9d\u6258\u5148\u8fdb\u7684\u5206\u5b50\u751f\u7269\u5b66\u53ca\u5927\u6570\u636e\u5206\u6790\u80fd\u529b\u6539\u53d8\u764c\u75c7\u8bca\u7597\u65b9\u5f0f\u3002\u6cdb\u751f\u5b50\u5df2\u6253\u9020\u4e86\u5168\u9762\u7684\u4ea7\u54c1\u53ca\u670d\u52a1\u7ba1\u7ebf\uff0c\u8986\u76d6\u4ece\u764c\u75c7\u65e9\u7b5b\u5230\u8bca\u65ad\u53ca\u6cbb\u7597\u5efa\u8bae\uff0c\u518d\u5230\u76d1\u6d4b\u53ca\u9884\u540e\u7ba1\u7406\u7684\u764c\u75c7\u5168\u5468\u671f\uff0c\u5e76\u4e0e\u4ea7\u4e1a\u94fe\u4e0a\u4e0b\u6e38\u5408\u4f5c\u4f19\u4f34\u79ef\u6781\u62d3\u5c55\u5206\u5b50\u68c0\u6d4b\u6280\u672f\u7684\u66f4\u591a\u521b\u65b0\u5e94\u7528\u65b9\u5411\u548c\u573a\u666f\u3002\u66f4\u591a\u516c\u53f8\u4fe1\u606f\u8bf7\u8bbf\u95ee\uff1a<a target=\"_blank\" href=\"https:\/\/www.genetronhealth.com\/\" rel=\"nofollow noopener\">https:\/\/www.genetronhealth.com\/<\/a>\u3002<\/p>\n<p><b>\u5b89\u5168\u6e2f\u58f0\u660e<\/b><\/p>\n<p>\u672c\u65b0\u95fb\u7a3f\u5305\u542b\u6cdb\u751f\u5b50\u5bf9\u672a\u6765\u7684\u9884\u671f\u3001\u8ba1\u5212\u548c\u524d\u77bb\u6027\u9648\u8ff0\uff0c\u5305\u62ec\u9488\u5bf9\u7814\u7a76\u6210\u679c\u53ca\u57fa\u56e0\u7ec4\u5b66\u63a2\u7d22\uff0c\u4ee5\u53ca\u751f\u7269\u4fe1\u606f\u6a21\u578b\u6784\u5efa\u548c\u4f18\u5316\u7814\u7a76\u7684\u9648\u8ff0\uff0c\u5177\u6709\u76f8\u5e94\u98ce\u9669\u53ca\u4e0d\u786e\u5b9a\u6027\uff0c\u53ef\u80fd\u5bfc\u81f4\u5b9e\u9645\u7ed3\u679c\u4e0e\u524d\u77bb\u6027\u9648\u8ff0\u4e2d\u63cf\u8ff0\u7684\u9884\u671f\u4e0d\u7b26\u3002\u6b64\u7c7b\u9648\u8ff0\u662f\u6839\u636e1995\u5e74\u7f8e\u56fd\u79c1\u6709\u8bc1\u5238\u8bc9\u8bbc\u6539\u9769\u6cd5\u6848\u7684\u201c\u5b89\u5168\u6e2f\u201d\u6761\u6b3e\u4f5c\u51fa\u7684\u3002\u524d\u77bb\u6027\u9648\u8ff0\u6d89\u53ca\u56fa\u6709\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\uff0c\u4ee5\u53ca\u8bb8\u591a\u53ef\u80fd\u5bfc\u81f4\u5b9e\u9645\u7ed3\u679c\u4e0e\u4efb\u4f55\u524d\u77bb\u6027\u9648\u8ff0\u4e2d\u6240\u63cf\u8ff0\u7684\u5185\u5bb9\u4ea7\u751f\u91cd\u5927\u5dee\u5f02\u7684\u56e0\u7d20\u3002\u5176\u5b83\u5305\u542b\u6709\u201c\u9884\u671f\u201d\u3001\u201c\u76f8\u4fe1\u201d\u3001\u201c\u671f\u5f85\u201d\u3001\u201c\u8ba1\u5212\u201d\u7b49\u63aa\u8f9e\u548c\u7c7b\u4f3c\u8868\u8fbe\u4e5f\u5c5e\u4e8e\u524d\u77bb\u6027\u63cf\u8ff0\u3002\u66f4\u591a\u6709\u5173\u8fd9\u4e9b\u5185\u5bb9\u53ca\u5176\u4ed6\u98ce\u9669\u3001\u4e0d\u786e\u5b9a\u6027\u56e0\u7d20\u7684\u4fe1\u606f\uff0c\u5df2\u5305\u542b\u5728\u516c\u53f8\u5411\u7f8e\u56fd\u8bc1\u5238\u4ea4\u6613\u59d4\u5458\u4f1a\u63d0\u4ea4\u7684\u5907\u6848\u6587\u4ef6\u4e2d\u3002\u672c\u65b0\u95fb\u7a3f\u4e2d\u63d0\u4f9b\u7684\u6240\u6709\u4fe1\u606f\u4e0d\u5e94\u88ab\u89c6\u4e3a\u672c\u516c\u544a\u53d1\u5e03\u4e4b\u65e5\u540e\u4efb\u4f55\u65f6\u70b9\u7684\u89c2\u70b9\u3002\u6cdb\u751f\u5b50\u9884\u8ba1\u672a\u6765\u7684\u4e8b\u4ef6\u548c\u8fdb\u5c55\u4f1a\u5bfc\u81f4\u516c\u53f8\u7684\u8bbe\u60f3\u548c\u5047\u8bbe\u53d1\u751f\u53d8\u5316\uff0c\u4f46\u65e0\u8bba\u662f\u5426\u51fa\u73b0\u4e86\u65b0\u7684\u4fe1\u606f\u3001\u672a\u6765\u4e8b\u4ef6\u6216\u5176\u5b83\u60c5\u51b5\uff0c\u9664\u9002\u7528\u6cd5\u5f8b\u8981\u6c42\u5916\uff0c\u516c\u53f8\u4e0d\u627f\u62c5\u66f4\u65b0\u4efb\u4f55\u524d\u77bb\u6027\u63cf\u8ff0\u7684\u4e49\u52a1\u3002<\/p>\n<p>\u76f8\u5173\u94fe\u63a5 :<\/p>\n<p>https:\/\/www.genetronhealth.com\/<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5c01\u9762\u6458\u8981\uff1a\u521b\u65b0\u6280\u672f\u53ca\u4ea7\u54c1\u8d4b\u80fd\u591a\u764c\u79cd\u57fa\u56e0\u7ec4\u5b66\u57fa\u7840\u7814\u7a76\uff0c\u52a9\u529b\u8f6c\u5316\u533b\u5b66\u201c\u826f\u6027\u5faa\u73af\u201d \u5317\u4eac2021\u5e744\u670814\u65e5 \/\u7f8e\u901a\u793e\/ &#8212; \u8fd1\u65e5\uff0c\u6cdb\u751f\u5b50\uff08\u7eb3\u65af\u8fbe\u514b\u4ee3\u7801\uff1aGTH\uff09\u57282021\u5e74\u7f8e\u56fd\u764c\u75c7\u7814\u7a76\u534f\u4f1a\u5e74\u4f1a\uff08AACR2021\uff09\u53d1\u5e03\u4e8622\u9879\u5168\u65b0\u7814\u7a76\u6210\u679c\u3002\u4f01\u4e1a\u8fd0\u7528RNA\u878d\u5408\u68c0\u6d4b\u3001\u65b0\u578bMSI\u68c0\u6d4b\u751f\u4fe1\u7b97\u6cd5\u6a21\u578b\u3001\u201c\u4e00\u6b65\u6cd5\u201d\u7b49\u521b\u65b0\u6280\u672f\uff0c\u53caOnco PanscanTM\u3001\u8089\u7624\u5168\u4f53\u7cfb\u57fa\u56e0\u68c0\u6d4b\u7b49\u6838\u5fc3\u4ea7\u54c1\uff0c\u643a\u624b13\u5bb6\u56fd\u5185\u9876\u7ea7\u533b\u9662\uff0c\u56f4\u7ed5\u4e2d\u56fd\u4eba\u7fa4\u6df1\u5165\u5206\u6790\u80ba\u764c\u3001\u80a0\u764c\u3001\u80f0\u817a\u764c\u3001\u795e\u7ecf\u7cfb\u7edf\u80bf\u7624\u3001\u80f8\u817a\u764c\u7b49\u591a\u764c\u79cd\u9057\u4f20\u3001\u7a81\u53d8\u3001\u878d\u5408\u7279\u5f81\u5206\u5e03\uff0c\u9a8c\u8bc1\u5e76\u6316\u6398\u591a\u764c\u79cd\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269\u6709\u6548\u6027\uff0c\u4ee5\u53ca\u7f55\u89c1\u6848\u4f8b\u548c\u65b0\u578b\u7597\u6cd5\uff0c\u8fdb\u800c\u4e3a\u764c\u75c7\u7cbe\u51c6\u8bca\u7597\u65b9\u5f0f\u3001\u8bca\u7597\u4ea7\u54c1\u8bbe\u8ba1\u7b49\u63d0\u4f9b\u91cd\u8981\u542f\u793a(\u9644\u7814\u7a76\u5217\u8868)\u3002 \u6cdb\u751f\u5b50\u9996\u5e2d\u533b\u7597\u5b98\u80e1\u4e91\u5bcc\u535a\u58eb\u8868\u793a\uff1a\u201c\u4f5c\u4e3a\u57fa\u7840\u7814\u7a76\u4e0e\u4e34\u5e8a\u5e94\u7528\u7684\u6865\u6881\uff0c\u6cdb\u751f\u5b50\u59cb\u7ec8\u81f4\u529b\u4e8e\u4e3a\u4e8c\u8005\u5efa\u7acb\u826f\u6027\u4e92\u4fc3\u5173\u7cfb\uff0c\u5168\u529b\u63a8\u52a8\u8f6c\u5316\u533b\u5b66\u53d1\u5c55\u3002\u672c\u6b21\u7814\u7a76\u6210\u679c\uff0c\u57fa\u4e8e\u4f01\u4e1a\u521b\u65b0\u6280\u672f\u53ca\u4ea7\u54c1\uff0c\u52a9\u529b\u591a\u764c\u79cd\u57fa\u56e0\u7ec4\u5b66\u7684\u7279\u5f81\u5206\u6790\u53ca\u6280\u672f\u4f18\u5316\u8def\u7ebf\u63a2\u7d22\uff0c\u5e76\u4e3a\u65b0\u4ea7\u54c1\u8bbe\u8ba1\u63d0\u4f9b\u601d\u8def\u3002\u5982\u5728\u8f6f\u7ec4\u7ec7\u8089\u7624\u9886\u57df\uff0c\u901a\u8fc7RNA\u878d\u5408\u68c0\u6d4b\u6280\u672f\uff0c\u5927\u5e45\u63d0\u9ad8\u878d\u5408\u68c0\u51fa\u7387\uff0c\u4e3a\u66f4\u591a\u8089\u7624\u60a3\u8005\u63d0\u4f9b\u83b7\u76ca\u53ef\u80fd\uff1b\u5728\u9057\u4f20\u6027\u80bf\u7624\u9886\u57df\uff0cLi-Fraumeni\u7efc\u5408\u5f81\u7b5b\u67e5\u65b9\u6cd5\u7684\u63d0\u51fa\u4e5f\u5c06\u63d0\u5347\u8be5\u7c7b\u60a3\u8005\u68c0\u51fa\u7387\uff0c\u4e3a\u5176\u63d0\u4f9b\u66f4\u591a\u5e72\u9884\u673a\u4f1a\uff1b\u5728\u7ed3\u76f4\u80a0\u764c\u9886\u57df\uff0cKMT2C\/2D\u5931\u6d3b\u7a81\u53d8\u7684\u5206\u6790\u4e5f\u5c06\u4e3a\u514d\u75ab\u6cbb\u7597\u9002\u7528\u60a3\u8005\u63d0\u4f9b\u66f4\u591a\u83b7\u76ca\u53ef\u80fd\u3002\u6b64\u5916\uff0c\u7f55\u89c1\u75c5\u4f8b\u6316\u6398\u53ca\u5176\u65b0\u578b\u7597\u6cd5\u7684\u5c1d\u8bd5\uff0c\u5c06\u63a8\u52a8\u8be5\u7c7b\u578b\u60a3\u8005\u7684\u8bca\u7597\u7814\u7a76\u8fdb\u4e00\u6b65\u53d1\u5c55\u3002\u201d \u63a2\u7d22\u6280\u672f\u4f18\u5316\u8def\u7ebf \u4e3a\u6253\u7834DNA-seq\u9488\u5bf9\u68c0\u6d4b\u57fa\u56e0\u878d\u5408\u6240\u5b58\u5728\u7684\u5c40\u9650\u6027\uff0c\u7814\u7a762288\u5bf9\u5e38\u89c4\u6280\u672f\u8fdb\u884c\u4f18\u5316\uff0c\u5728RNA\u5c42\u9762\u5b9e\u73b0\u4e86\u66f4\u7cbe\u51c6\u3001\u9ad8\u6548\u3001\u4f4e\u8017\u7684\u878d\u5408\u57fa\u56e0\u7a81\u53d8\u68c0\u6d4b\uff0c\u5728142\u4eba\u7684\u8f6f\u7ec4\u7ec7\u8089\u7624\u961f\u5217\u4e2d\u8fdb\u884c\u8bc4\u4f30\u53ca\u9a8c\u8bc1\u3002\u7814\u7a76\u663e\u793a\u76f8\u6bd4DNA\u5355\u72ec\u68c0\u6d4b\uff0cDNA+RNA\u7efc\u5408\u68c0\u6d4b\u5bf9\u4e8e\u8f6f\u7ec4\u7ec7\u8089\u7624\u878d\u5408\u7684\u68c0\u51fa\u7387\u63d0\u9ad8\u4e86177%\uff0c\u53ef\u4e3a\u66f4\u591a\u8089\u7624\u60a3\u8005\u63d0\u4f9b\u4e34\u5e8a\u83b7\u76ca\u53ef\u80fd\u3002 \u7814\u7a762080\u5bf9NGS MSI\u751f\u4fe1\u7b97\u6cd5\u8fdb\u884c\u4e86\u591a\u91cd\u4f18\u5316\uff0c\u5e76\u4e0e\u91d1\u6807\u51c6PCR\u5bf9\u6bd4\uff0c\u57282523\u4f8b\u6cdb\u764c\u79cd\u5927\u6837\u672c\u4e2d\u8fdb\u884c\u9a8c\u8bc1\u3002\u7ed3\u679c\u8868\u660e\uff0c\u4f18\u5316\u540e\u7684\u7b97\u6cd5\u4e0e\u91d1\u6807\u51c6PCR\u68c0\u6d4b\u65b9\u6cd5\u4e00\u81f4\u6027\u8fbe99.9%\u3002\u5176\u4e2dMSI-H\u9633\u6027\u9884\u6d4b\u7387PPV\u4e3a98.73%\uff0cMSS\u9634\u6027\u9884\u6d4b\u7387NPV\u4e3a99.92%\u3002 \u5173\u6ce8\u9057\u4f20\u6027\u80bf\u7624\u7279\u5f81 \u4e24\u9879\u7814\u7a76\uff08#1464\u3001#2557\uff09\u901a\u8fc7\u5bf9\u80da\u7cfb\u7a81\u53d8\u7684\u6df1\u5165\u5206\u6790\uff0c\u4e3aLi-Fraumeni\u7efc\u5408\u5f81\u63d0\u4f9b\u4e86\u7b5b\u67e5\u65b9\u6cd5\uff0c\u63a2\u8ba8\u4e86\u4e2d\u56fd\u4eba\u7fa4\u80f0\u817a\u764c\u60a3\u8005\u9057\u4f20\u7279\u5f81\u53ca\u5177\u4f53\u5206\u5e03\uff0c\u4e3a\u9057\u4f20\u6027\u80bf\u7624\u7b5b\u67e5\u53ca\u8bca\u7597\u63d0\u4f9b\u8bc1\u636e\u53ca\u601d\u8def\u3002 \u63a2\u7d22\u57fa\u56e0\u7a81\u53d8\u53ca\u878d\u5408\u7279\u5f81 \u4e5d\u9879\u7814\u7a76\uff08#2217\u3001#2163\u3001#2223\u3001#2216\u3001#2215\u3001#2313\u3001#2252\u3001#2183\u3001#2182\uff09\u5206\u522b\u5bf9\u8f6f\u7ec4\u7ec7\u8089\u7624\u3001\u9ed1\u8272\u7d20\u7624\u3001\u795e\u7ecf\u5185\u5206\u6ccc\u80bf\u7624\u3001\u975e\u5c0f\u7ec6\u80de\u80ba\u764c\u3001\u80f8\u817a\u764c\u3001\u5c0f\u80a0\u817a\u764c\u3001\u58f6\u8179\u764c\u7b49\u591a\u4e2a\u764c\u79cd\u8fdb\u884c\u7a81\u53d8\u3001\u878d\u5408\u7279\u5f81\u591a\u7ef4\u5ea6\u63a2\u7d22\uff0c\u5bfb\u627e\u6f5c\u5728\u7cbe\u51c6\u6cbb\u7597\u9776\u70b9\u3001\u8010\u836f\u9776\u70b9\u53ca\u6709\u6548\u5e94\u5bf9\u63aa\u65bd\u3002 \u6316\u6398\u514d\u75ab\u6cbb\u7597\u6807\u5fd7\u7269 \u56db\u9879\u7814\u7a76\uff08#1639\u3001#1640\u3001#1641\u3001#1681\uff09\u5206\u522b\u63a2\u8ba8\u4e86KMT2C\/D\u5931\u6d3b\u7a81\u53d8\u3001DDR\u4fe1\u53f7\u901a\u8def\u76f8\u5173\u57fa\u56e0\u53d8\u5f02\u3001ARID1A\u7a81\u53d8\u4ee5\u53caBRCA1\/2\u7a81\u53d8\u5bf9\u6cdb\u764c\u79cd\u514d\u75ab\u6cbb\u7597\u7597\u6548\u7684\u9884\u6d4b\u4f5c\u7528\uff0c\u4e3a\u514d\u75ab\u6cbb\u7597\u63d0\u4f9b\u542f\u793a\u3002 \u5173\u6ce8\u7f55\u89c1\u6848\u4f8b\u53ca\u65b0\u578b\u7597\u6cd5 \u4e94\u9879\u7814\u7a76\uff08#0803\u3001#0422\u3001#1209\u3001#1199\u3001#0625\uff09\u5206\u522b\u5728\u6797\u5947\u7efc\u5408\u5f81\u76f8\u5173\u80ba\u764c\u3001\u8f6c\u79fb\u6027\u9ed1\u8272\u7d20\u7624\u3001\u95f4\u53d8\u6027\u7532\u72b6\u817a\u764c\u3001\u7532\u72b6\u817a\u4e73\u5934\u72b6\u764c\u4ee5\u53ca\u8102\u80aa\u8089\u7624\u60a3\u8005\u4e2d\u68c0\u6d4b\u51fa\u7279\u6b8a\u7684\u5206\u5b50\u5f02\u5e38\u3002\u7814\u7a76\u901a\u8fc7\u5206\u5b50\u68c0\u6d4b\u8f85\u52a9\u60a3\u8005\u8fdb\u884c\u8bca\u65ad\u5206\u578b\uff0c\u4e3a\u60a3\u8005\u91c7\u7528\u65b0\u578b\u7684\u9776\u5411\u6cbb\u7597\u3001\u514d\u75ab\u6cbb\u7597\u65b9\u6848\uff0c\u6700\u7ec8\u4f7f\u60a3\u8005\u6210\u529f\u83b7\u76ca\u3002 \u7f16\u53f7 \u9898\u76ee 1464 Enrichment and screening of LFS patients by analyzing TP53 germline mutations ofa Chinese cancer cohort 2252 Genome profiling of thymic carcinoma identifies putative driver mutations in the NF-\u03baB signaling pathway 2557 Germline mutation&hellip; <a class=\"read-more\" href=\"https:\/\/www.xinwengao.com\/cn\/pr\/2021041412590026537\">Read More<\/a><\/p>\n","protected":false},"author":556,"featured_media":8278,"comment_status":"close","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1965],"tags":[],"class_list":["post-26537","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-partnerships"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/26537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/users\/556"}],"replies":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/comments?post=26537"}],"version-history":[{"count":2,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/26537\/revisions"}],"predecessor-version":[{"id":26540,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/posts\/26537\/revisions\/26540"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media\/8278"}],"wp:attachment":[{"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/media?parent=26537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/categories?post=26537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.xinwengao.com\/cn\/wp-json\/wp\/v2\/tags?post=26537"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}